Across TCGA pan-cancer cohorts, DPY19L2P5 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of DPY19L2P5’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where DPY19L2P5 RNA is repressed in tumor relative to normal tissue. In most cancer types DPY19L2P5 is over-expressed in tumor, although a few such as UCEC and THCA show the opposite, repressed pattern.

UCEC, BRCA, and THCA are the cancer types where DPY19L2P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DPY19L2P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	III,IV	−0.204	.027	4	view →
BRCA	All	II,III,IV	+0.032	.033	4	view →
THCA	All	All	−0.165	<.001	3	view →
LUSC	Male	All	−0.138	.003	3	view →
KICH	All	All	−0.154	.014	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: DPY19L2P5 RNA expression & survival · all DPY19L2P5 data types